Pasar al contenido principal

IDENTIFICACION Y CARACTERIZACION DE BIOMOLECULAS EN LA SALIVA DE GARRAPATAS Y MECANISMOS ASOCIADOS CON LA RESPUESTA INMUNE FRENTE A ALPHA-GAL

PID2020-116761GB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Tesis doctoral (DoctoralThesis)

Vaccines for the control of cattle ticks in Uganda

  • Kasaija, Paul D.
Doctorado en Ciencias Agrarias y Ambientales., [Chapter I]: Ticks and tick-borne diseases have a negative impact on human and animal health worldwide. Ticks are the most important vectors of pathogen that cause economically important diseases in animals and affect human health and are widespread in Uganda due to the suitable climatic conditions. Traditional tick control methods are primarily based on the use of chemical acaricides, which can result in the selection of resistant ticks, environmental pollution, and contamination of milk and meat products with residues affecting in particular the cattle industry, resulting into economic losses., [General Introduction]: which describes the epidemiology of ticks and tick-borne diseases (TBDs) and their economic impact in Uganda. This chapter is a review paper [Kasaija, P.D., Estrada-Peña, A., Contreras, M., Kirunda, H., de la Fuente, J. (2021). Ticks and tick-borne diseases: a review of Uganda’s situation. Ticks and Tick-Borne Diseases 12, 101756] about how cattle are affected by TBDs. Due to the suitable climatic conditions, ticks are widespread in Uganda and cause over USD 1.1 billion of economics losses. Among the tick species in Uganda, the most economically important ticks are Rhipicephalus decoloratus, R. appendiculatus, and A. variegatum. In this country, exotic cattle breeds are more susceptible to ticks and the diseases they transmit than indigenous cattle, demanding intensive use of acaricides for tick control and prevention of TBDs. Consequently, the abusive use of these acaricides leads to the selection of acaricide-resistant tick populations. In this context, vaccination could be an effective alternative, that also integrated with tick control approaches that limit tick exposure, could disrupt the spread of ticks and TBDs., [Chapter II]: Design and evaluation of Subolesin-based vaccines for the control of cattle tick infestations in Uganda. Chapter I describes how vaccines are a feasible alternative to acaricide control of tick infestation in mammalian hosts. Immunization with recombinant SUB results in hosts (cattle) protection against infestation by decreasing tick survival and reproduction rates. The SUB protein sequences from the ticks R. decoloratus, R. appendiculatus, and A. variegatum from Uganda are highly homologous (75% amino acid identity), which explains the observed cross-protection [Kasaija, P.D., Contreras, M., Kabi, F., Mugerwa, S., de la Fuente, J. (2020). Vaccination with recombinant Subolesin antigens provides cross-tick species protection in Bos indicus and crossbred cattle in Uganda. Vaccines 8,319]. Cattle vaccination with SUB vaccine formulations induces sustained antigen-specific IgG production that affects various tick developmental stages with minor differences between tick species. The higher vaccine efficacy observed in crossbreed cattle reflects the influence of the host’s genotype on the immune response. Vaccination with a combination of SUB antigens from the different tick species produces limited vaccine efficacy. Nevertheless, study results suggest the possibility of using SUB-based antigens for the control of multiple tick species in different cattle breeds of Uganda. Additionally, in this chapter Quantum vaccinomics approach is used to identify B-cell reactive epitopes by mapping antigen peptides in a microarray using sera from vaccinated cattle. The reactive and conserved SUB peptides identified using epitope-mapping methods may have an influence on the vaccine efficacy and immunological protection observed and could thus constitute chimeric SUB antigens for production of cross-protective and personalised anti-tick vaccines [Contreras, M., Kasaija, P.D., Kabi, F., Mugerwa, S., de la Fuente, J. (2022). The correlation between Subolesin-reactive epitopes and vaccine efficacy. Vaccines 10, 1327.]., [Chapter III]: Design and evaluation of oral vaccine formulations based on Subolesin and heat inactivated mycobacteria immunostimulant for the control of cattle tick infestations in Uganda.In this chapter includes and optimization of vaccine formulations, including the possibility of oral administration to improve cattle welfare and safety. Orally administered SUB vaccine formulations, such as SUB+IV, improved vaccine delivery and safety. The SUB+IV vaccine antigens activate both the innate and adaptive immune pathways which improves overall vaccine efficacy [Contreras, M., Kasaija, P.D., Merino, O., de la Cruz-Hernandez, N.I., Gortazar, C., de la Fuente, J. (2019). Oral vaccination with a formulation combining R. microplus Subolesin with heat inactivated Mycobacterium bovis reduces tick infestations in cattle. Frontiers in Cellular and Infection Microbiology 9, 45]. In a second study including in this chapter, oral R. decoloratus SUB with IV vaccine formulation showed good results for controlling tick infestations of R. appendiculatus and R. decoloratus [Kasaija, P.D., Contreras, M., Kabi, F., Mugerwa, S., Garrido, J.M., Gortazar, C., de la Fuente, J. (2022). Oral vaccine formulation combining tick Subolesin with heat inactivated mycobacteria provides control of cross-species cattle tick infestations. Vaccine 40,4564-4573]., [Chapter IV]: General discussion Chapter IV is presented as a general discussion with an overview of interventions and challenges for the control of ticks and tick-borne diseases in Uganda, being a priority for the Government of Uganda to promote economic growth in the country. A multidisciplinary approach to combining different control measures including cattle management and the rational use of acaricides and the development and application of anti-tick vaccines are proposed in this chapter. In addition, collaboration between research institutions specialized in these areas with those located in the affected countries is necessary to achieve these goals [de la Fuente, J., Contreras, M., Kasaija, P.D., Gortázar, C., Ruiz-Fons, J.F., Mateo, R., Kabi, F. (2019). Towards a multidisciplinary approach to improve cattle health and production in Uganda. Vaccines 7: 165]. As an example of these approaches and collaborations this chapter also includes a collaboration program that was established between the group of Health and Biotechnology (SaBio) of the IREC Institute of Game and Wildlife Research (CSIC-UCLM-JCCM, Spain) and the National Agricultural Research Organization of Uganda (NARO) for the development of vaccines for the control of cattle ticks in Uganda. In this context, a controlled pen trials identified a tick protective antigen, R. appendiculatus SUB, and a cross-species-effective vaccine formulation was designed and exposed in this chapter [Kabi, F., Dhikusooka, M., Matovu, M., Mugerwa, S., Kasaija, P., Emudong, P., Kirunda, H., Contreras, M., Gortázar, C., de la Fuente, J. (2022). Monitoring the Subolesin vaccine field trial for safer control of cattle ticks amidst increasing acaricide resistance in Uganda. Vaccines 10: 1594]., The realization of this research work has been made possible by the financial support of the following entities and projects: This research was financially supported by the Ministerio de Economía, Industria y Competitividad (Spain) grant BFU2016-79892-P. Junta de Castilla-La Mancha, Spain, project MYCOTRAINING SBPLY/19/180501/000174. State Research Agency, Spain, project BIOGAL [PID2020-116761 GB-I00]. National Agricultural Research Organization (NARO). Consejo Superior de Investigaciones Científicas., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Tesis doctoral (DoctoralThesis)

Identification and characterization of tick salivary biomolecules and mechanisms associated with the immune response to alpha-Gal, Identificación y caracterización de biomoléculas en la saliva de garrapatas y mecanismos asociados con la respuesta inmune frente a alpha-Gal

  • Vaz Rodrigues, Rita
Trabajo de investigación presentado por Rita Vaz Rodrigues para optar al grado de Doctora con mención internacional por la Universidad de Castilla-La Mancha. Programa de Doctorado en Ciencias Agrarias y Ambientales. Instituto de Investigación en Recursos Cinegéticos (IREC, CSIC-UCLM-JCCM). Grupo SaBio – Sanidad y Biotecnología Departamento de Ciencia y Tecnología Agroforestal y Genética., [EN] The alfa-Gal syndrome (AGS) is characterized by an immunoglobulin (Ig)E-mediated type I delayed hypersensitivity reaction to the oligosaccharide galactose-alpha-1,3-galactose (alpha-Gal). Old-World monkeys, apes and humans evolved with the inability to synthesize alpha-Gal epitopes, thus producing natural anti-alpha-Gal antibodies when exposed to this moiety, normally in response to gut bacteria or pathogen infection. Initial IgE sensitization is primarily attributed to alpha-Gal bound to tick salivary glycoproteins or glycolipids, however other biomolecules without alpha-Gal modifications may also play a role. Evidence shows that bites from hard-bodied tick species such as Ixodes ricinus in Europe, Amblyomma americanum in North America, Haemaphysalis longicornis in Asia, and Ixodes holocyclus in Australia act as triggers for AGS. Clinically, AGS is a shapeshifter, with symptoms ranging from delayed anaphylaxis to gastrointestinal, cutaneous, and respiratory manifestations that occur two to six hours after the consumption of alpha-Gal-containing foods or pharmaceuticals. Previous studies have primarily focused on uncovering the global immunological effects of tick saliva at sensitization site and associated serological changes, leaving gaps in understanding which specific tick salivary biomolecules trigger IgE sensitization. Animal models play a crucial role in advancing biomedical research by providing insights into pathological and biological processes. Due to their functional and genetic homology with humans, zebrafish (Danio rerio) represent a relevant model to study allergic reactions and immune mechanisms triggered by tick salivary substances and mammalian meat consumption. Additionally, progressing from zebrafish to a humanized mouse model for AGS pathogenesis studies increases translational value due to greater physiological and immunological similarity to humans. Accordingly, the murine model was engineered by knockout of the gene α-1,3-galactosyltransferase (α1,3GalT-KO) on a C57BL/6 background. The present doctoral thesis aimed to identify and characterize the role of tick salivary biomolecules in AGS and related allergic responses by integrating in vitro and in vivo models and applying a multi-omics approach. Additionally, clinical cases were incorporated to investigate the role of other arthropod bites in AGS onset, while public perceptions of tick bites and AGS were also assessed., [ES] El síndrome alfa-Gal (SAG) se caracteriza por una reacción de hipersensibilidad retardada de tipo I mediada por la inmunoglobulina E (IgE) frente al oligosacárido galactosa-alfa-1,3-galactosa (alfa-Gal). Los monos del Viejo Mundo, los simios y los humanos evolucionaron sin la capacidad de sintetizar epítopos de alfa-Gal, lo que conlleva la producción natural de anticuerpos anti-alfa-Gal tras la exposición a esta molécula, normalmente en respuesta a bacterias intestinales o agentes patogénicos. La sensibilización inicial de tipo IgE se atribuye principalmente al alfa-Gal unido a glicoproteínas o glicolípidos salivales de garrapata. Sin embargo, otras biomoléculas sin modificaciones de alfa-Gal también podrían estar implicadas. La evidencia indica que las picaduras de garrapatas duras, como Ixodes ricinus en Europa, Amblyomma americanum en América del Norte, Haemaphysalis longicornis en Asia e Ixodes holocyclus en Australia, actúan como desencadenantes del SAG. Clínicamente, el SAG presenta un perfil camaleónico, con síntomas que van desde anafilaxia retardada hasta manifestaciones gastrointestinales, cutáneas y respiratorias que ocurren entre dos y seis horas tras el consumo de alimentos o fármacos que contienen alfa-Gal. Estudios previos se han centrado en los efectos inmunológicos de la saliva de garrapata en el sitio de sensibilización y en los cambios serológicos asociados, dejando lagunas sobre qué biomoléculas salivales desencadenan la sensibilización mediada por IgE. Los modelos animales desempeñan un papel crucial en el avance de la investigación biomédica al proporcionar información sobre procesos patológicos y biológicos. Debido a su homología funcional y genética con los humanos, el pez cebra (Danio rerio) representa un modelo relevante para estudiar las reacciones alérgicas y los mecanismos inmunológicos desencadenados por componentes salivales de garrapatas y el consumo de carne roja. Además, la transición del pez cebra a un modelo murino humanizado para estudiar la patogénesis del SAG incrementa el valor traslacional, ya que ofrece una mayor similitud fisiológica e inmunológica con los seres humanos. En consecuencia, este modelo murino fue desarrollado mediante la inactivación del gen de la alfa-1,3-galactosiltransferasa (α1,3GalT-KO) en un fondo genético C57BL/6. La presente tesis doctoral tuvo como objetivo identificar y caracterizar el papel de biomoléculas salivales de garrapata en el SAG y en respuestas alérgicas relacionadas, integrando modelos in vitro e in vivo y aplicando un enfoque multi-ómico. Además, se incorporaron casos clínicos para investigar el papel de otras picaduras de artrópodos en el desencadenamiento del SAG, y se evaluaron percepciones públicas sobre las picaduras de garrapata y el SAG., La presente tesis doctoral ha sido financiada por las siguientes entidades: Universidad de Castilla-La Mancha (UCLM): Contrato predoctoral (2022-PRED-20675) para la formación de personal investigador en el marco del Plan Propio de I+D+i de la UCLM, cofinanciado por el Fondo Social Europeo (FSE+), resolución de febrero de 2022. Ministerio de Ciencia, Innovación y Universidades: Proyectos I+D+i – modalidades retos investigación y generación de conocimiento, convocatoria 2020, “Identificación y caracterización de biomoléculas en la saliva de garrapatas y mecanismos asociados con la respuesta inmune frente a α-Gal (BIOGAL)”, con referencia administrativa PID2020-116761GB-I00., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Tesis doctoral (DoctoralThesis)

Characterization of the immune response to alpha-gal antigen and possibilities for the control of infectious diseases, Caracterización de la respuesta inmune frente al antígeno alfa-Gal y posibilidades para el control de enfermedades infecciosas

  • Pacheco, Iván
Trabajo de investigación presentado por Iván Pacheco Carrillo para optar al grado de Doctor por la Universidad de Castilla-La Mancha., [EN] Ticks are blood-feeding arthropod ectoparasite vectors of pathogens affecting human and animal health worldwide by increasing the prevalence of infectious diseases and allergic reactions such as the Alpha-Gal Syndrome (AGS). Actually, tick-borne pathogens (TBPs) implicated in infestations and disease development are controlled mainly using chemical acaricides, with the harmful causes they generate on the environment and the selection of resistant ticks. Vaccines are considered the most effective and eco-sustainable solution to control pathogen infection, multiplication and transmission, which is why omics technologies and bioinformatic tools have been optimized at the molecular and physiological level, identifying possible candidate protective antigens. This doctoral thesis focuses on the characterization of the role of the carbohydrate alpha-Gal in vector-host-pathogen molecular interactions and the AGS. The results support alpha-Gal as candidate antigen to develop vaccines for the control of major infectious diseases and reduce the use of acaracides in support of the One Health approach., [ES] Las garrapatas son ectoparásitos artrópodos que se alimentan de sangre. Actúan como vectores de patógenos, afectando la salud humana y animal por todo el mundo al aumentar la prevalencia de enfermedades infecciosas y reacciones alérgicas como es el síndrome de alfa-Gal (AGS). Actualmente, los patógenos transmitidos por garrapatas (TBPs) implicados en infestaciones y desarrollo de enfermedades son controlados principalmente mediante acaricidas químicos, con los efectos nocivos que éstos pueden generar tanto sobre el medio ambiente, como por la selección de garrapatas resistentes. Las vacunas son consideradas como la solución más eficaz y ecosostenible para controlar la infección, multiplicación y transmisión de patógenos, por lo que las tecnologías ómicas y herramientas bioinformáticas se han optimizado a nivel molecular y fisiológico, identificando posibles candidatos como antígenos protectores. Esta tesis doctoral se centra en la caracterización del papel del carbohidrato alfa-Gal en las interacciones moleculares vector-hospedador-patógeno y el AGS. Los resultados respaldan como antígeno candidato a la molécula de alfa-Gal para el desarrollo de vacunas para el control de las principales enfermedades infecciosas y, con ello, reducir el uso de acaricidas en apoyo del concepto de “Una Salud”., La realización de esta tesis ha sido posible gracias a las siguientes entidades y proyectos: Consejería de Educación, Cultura y Deportes, JCCM: proyecto CCM17-PIC-036 (SBPLY/17/180501/000185) cofinanciado por parte de la Junta de Castilla-La Mancha y del Fondo Europeo de Desarrollo Regional (FEDER), respetando lo dispuesto en el anexo XII del reglamento (UE) 1303/2013. Ministerio de Ciencia e Innovación: Identificación y caracterización de biomoléculas en la saliva de garrapatas y mecanismos asociados con la respuesta inmune frente a alpha-Gal (BIOGAL); PID2020-116761GB-I00., Peer reviewed